Valvular & structural heart disease

Transcatheter Aortic Valve Implantation by Valve Type in Women With Small Annuli: Results From the SMART Randomized Clinical Trial

JAMA CardiolPublished Prespecified secondary analysis of the SMART randomised trial

Authors' conclusion

Among women with severe symptomatic aortic stenosis and small aortic annuli undergoing transcatheter aortic valve replacement, the use of SEVs, compared to BEVs, resulted in similar clinical outcomes and a markedly reduced incidence of bioprosthetic valve dysfunction through 12 months, including a lower risk of prosthesis-patient mismatch and better 12-month quality of life.

Study context

Population
Women with small aortic annuli undergoing TAVR, Canada, Europe, Israel and USwomen of 716 in SMART
Participants
621 women
Comparison
Self-expanding valve vs balloon-expandable valve in TAVR
  • Self-expanding valve (SEV)n = 312
  • Balloon-expandable valve (BEV)n = 309reference
Primary endpoint
Coprimary: death, disabling stroke or HF rehospitalization; and bioprosthetic valve dysfunction
Follow-up
12 months
Methodological detailsmulticentre (83 centres)
  • Multicentre (83 centres)

Primary result

As reported in the abstract

SEV

Clinical end point
9.4%
Bioprosthetic valve dysfunction
8.4%

BEV

Clinical end point
11.8%
Bioprosthetic valve dysfunction
41.8%

Clinical end point

SEV9.4%
BEV11.8%

Bioprosthetic valve dysfunction

SEV8.4%
BEV41.8%
SEV vs BEVAbsolute risk difference (95% CI)P value
Clinical end point
−2.3%(−7.2 to 2.5)
P = 0.35
Bioprosthetic valve dysfunction
−33.4%(−40.4 to −26.4)
P < 0.001

Secondary outcomes

Hemodynamics · 30 days and 12 months

SEV: lower aortic valve gradients and larger effective orifice areas; less mild or greater aortic regurgitation at 12 months

Prosthesis-patient mismatch

Significantly lower with SEVs, regardless of definition and BMI adjustment

Quality of life (VARC-3 ordinal measure)

Better with SEVs

Original publication

Transcatheter Aortic Valve Implantation by Valve Type in Women With Small Annuli: Results From the SMART Randomized Clinical Trial. JAMA Cardiol. Published 1 December 2024. doi:10.1001/jamacardio.2024.3241

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.